| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +47.2K | 5.6% | $2.12 | +$100K |
| Sells | 1 | -788K | 94.4% | $1.23 | -$967K |
| Net | +2 | -741K | -88.7% | -$867K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Thomas Woiwode | Director | $5M | Jun 17, 2022 | ||
| Versant Vantage II, L.P. | 10%+ Owner | $5M | Apr 29, 2022 | ||
| Versant Venture Capital VI, L.P. | 10%+ Owner | $2.56M | -$967K | -27.4% | Aug 8, 2024 |
| Stella Xu | Director | $1.37M | Jul 1, 2021 | ||
| Thomas W. Dubensky | President, Director | $267K | Jan 3, 2023 | ||
| Rock Springs Capital Management LP | 10%+ Owner | $174K | Dec 30, 2021 | ||
| Stephen R. Brady | President and CEO, Director | $97.9K | +$73.9K | +308% | Jul 3, 2024 |
| Justin Trojanowski | Corporate Controller | $47.9K | +$16.2K | +51.1% | Jun 28, 2024 |
| Samuel Whiting | Chief Medical Officer | $20.4K | +$9.95K | +95.3% | Jul 2, 2024 |
| Pierre Lorenzo | Corporate Controller | $125 | Jun 21, 2022 | ||
| Nicholas Maestas | VP of Strategy and Finance | Jan 3, 2024 | |||
| Michael Raab | Director | Jun 13, 2024 | |||
| Geoffrey Nichol | Director | Jun 13, 2024 | |||
| Ronit Simantov | Director | Jun 13, 2024 | |||
| Christine A. Pellizzari | Director | Jun 13, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|